The role of SIRT6 in tumorigenesis and development remains controversial, although it can act as an oncogene in breast cancer [21,22], prostate cancer [23,24], HCC [25], and diffuse large B-cell lymphoma by inducing cancer cell proliferation, metastasis, and chemoresistance [26]. This evidence concerns the gene SIRT6 and prostate cancer.